Amygdalus persica
Amygdalus persica is an FDA drug label for the active ingredient PRUNUS PERSICA FLOWER manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231018.
Generic: PRUNUS PERSICA FLOWER
Manufacturer: Boiron
Product Type: HUMAN PRESCRIPTION DRUG
Route: ORAL
Dosage Form:
NDC: 0220-0296
Application:
Effective: 20231018
Active Ingredients: Amygdalus persica 30C (**contains 0.443 mg of the active ingredient per pellet)
Indications & Usage
Rx Only*
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.
More from same ingredient
No related products.